Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...
When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...
Rapid-acting inhaled insulin (Afrezza) is under FDA review for children ages 4 to 17 with diabetes, said maker MannKind. If ...
Explore how functional ingredients are challenging GLP-1 drugs in weight management – and what this shift means for food and ...
Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...
GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...
With celebrities like Serena Williams discussing GLP-1s in PEOPLE and Rebel Wilson partnering with Noom, weight-loss ...
For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says. Scientists at Duke ...
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking ...
With the explosion in popularity of GLP-1 drugs like Ozempic, another industry has popped up, claiming to offer “natural” ...